These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10335399)

  • 1. Human immunodeficiency virus type 1 entry and chemokine receptors: a new therapeutic target.
    Cammack N
    Antivir Chem Chemother; 1999 Mar; 10(2):53-62. PubMed ID: 10335399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-receptors for HIV-1 entry.
    Moore JP; Trkola A; Dragic T
    Curr Opin Immunol; 1997 Aug; 9(4):551-62. PubMed ID: 9287172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
    Xiao X; Kinter A; Broder CC; Dimitrov DS
    Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways.
    Lee C; Liu QH; Tomkowicz B; Yi Y; Freedman BD; Collman RG
    J Leukoc Biol; 2003 Nov; 74(5):676-82. PubMed ID: 12960231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In a human lymphomyeloid progenitor cell line (KG-1) HIV-1 gp120 binds to chemokine-receptors CXC-R4 and CCR5, only in the presence of CD4.
    Re MC; Vignoli M; Furlini G; Ramazzotti E; Maldini C; La Placa M
    New Microbiol; 1999 Oct; 22(4):365-8. PubMed ID: 10555208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.
    Donzella GA; Schols D; Lin SW; Esté JA; Nagashima KA; Maddon PJ; Allaway GP; Sakmar TP; Henson G; De Clercq E; Moore JP
    Nat Med; 1998 Jan; 4(1):72-7. PubMed ID: 9427609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bis-azo compound FP-21399 inhibits HIV-1 replication by preventing viral entry.
    Zhang JL; Choe H; Dezube BJ; Farzan M; Sharma PL; Zhou XC; Chen LB; Ono M; Gillies S; Wu Y; Sodroski JG; Crumpacker CS
    Virology; 1998 May; 244(2):530-41. PubMed ID: 9601521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 coreceptors and their inhibitors.
    Ray N; Doms RW
    Curr Top Microbiol Immunol; 2006; 303():97-120. PubMed ID: 16570858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion.
    Finnegan CM; Rawat SS; Cho EH; Guiffre DL; Lockett S; Merrill AH; Blumenthal R
    J Virol; 2007 May; 81(10):5294-304. PubMed ID: 17344303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5.
    Dragic T; Trkola A; Thompson DA; Cormier EG; Kajumo FA; Maxwell E; Lin SW; Ying W; Smith SO; Sakmar TP; Moore JP
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5639-44. PubMed ID: 10779565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of the determinants of CCR5 and CXCR4 co-receptor function.
    Dragic T
    J Gen Virol; 2001 Aug; 82(Pt 8):1807-1814. PubMed ID: 11457985
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics.
    Reeves JD; Gallo SA; Ahmad N; Miamidian JL; Harvey PE; Sharron M; Pohlmann S; Sfakianos JN; Derdeyn CA; Blumenthal R; Hunter E; Doms RW
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16249-54. PubMed ID: 12444251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 entry and its inhibition.
    Pierson TC; Doms RW
    Curr Top Microbiol Immunol; 2003; 281():1-27. PubMed ID: 12932074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine receptors and human immunodeficiency virus infection.
    Bieniasz PD; Cullen BR
    Front Biosci; 1998 Jan; 3():d44-58. PubMed ID: 9407151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations.
    Pastore C; Nedellec R; Ramos A; Pontow S; Ratner L; Mosier DE
    J Virol; 2006 Jan; 80(2):750-8. PubMed ID: 16378977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.
    Hug P; Lin HM; Korte T; Xiao X; Dimitrov DS; Wang JM; Puri A; Blumenthal R
    J Virol; 2000 Jul; 74(14):6377-85. PubMed ID: 10864648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation.
    Liu QH; Williams DA; McManus C; Baribaud F; Doms RW; Schols D; De Clercq E; Kotlikoff MI; Collman RG; Freedman BD
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4832-7. PubMed ID: 10758170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells.
    Singer II; Scott S; Kawka DW; Chin J; Daugherty BL; DeMartino JA; DiSalvo J; Gould SL; Lineberger JE; Malkowitz L; Miller MD; Mitnaul L; Siciliano SJ; Staruch MJ; Williams HR; Zweerink HJ; Springer MS
    J Virol; 2001 Apr; 75(8):3779-90. PubMed ID: 11264367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition.
    Panos G; Watson DC
    Crit Rev Microbiol; 2015; 41(4):473-87. PubMed ID: 24635642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in targeting HIV-1 entry.
    Ryser HJ; Flückiger R
    Drug Discov Today; 2005 Aug; 10(16):1085-94. PubMed ID: 16182193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.